(Q41018165)

25 September 2017

title

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials (English)

1 reference

25 September 2017

0 references

J Parsonnet

1 reference

25 September 2017

R A Harris

series ordinal

1 reference

25 September 2017

H M Hack

series ordinal

1 reference

25 September 2017

D K Owens

series ordinal

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

348

1 reference

25 September 2017

issue

9021

1 reference

25 September 2017

page(s)

150-154

1 reference

Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Helicobacter pylori infection and the risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Markov models in medical decision making: a practical guide.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Life expectancy in four U.S. racial/ethnic populations: 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

H pylori and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

The Sydney System: epidemiology and natural history of chronic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Helicobacter pylori infection in children: potential clues to pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Some of the tough decisions required by a national health plan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

Designing a cost-effective clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901501-2

7 January 2021

10.1016/S0140-6736(96)01501-2

Identifiers

DOI

1 reference

25 September 2017

1 reference